Search details
1.
Early cardiac response is possible in stage IIIb cardiac AL amyloidosis and is associated with prolonged survival.
Blood
; 140(18): 1964-1971, 2022 11 03.
Article
in English
| MEDLINE | ID: mdl-35772003
2.
A real-life study of daratumumab combinations in newly diagnosed patients with light chain (AL) amyloidosis.
Hematol Oncol
; 42(4): e3289, 2024 Jul.
Article
in English
| MEDLINE | ID: mdl-38824453
3.
Prospective urinary albumin/creatinine ratio for diagnosis, staging, and organ response assessment in renal AL amyloidosis: results from a large cohort of patients.
Clin Chem Lab Med
; 60(3): 386-393, 2022 02 23.
Article
in English
| MEDLINE | ID: mdl-35018751
4.
Lenalidomide and dexamethasone in relapsed/refractory immunoglobulin light chain (AL) amyloidosis: results from a large cohort of patients with long follow-up.
Br J Haematol
; 195(2): 230-243, 2021 10.
Article
in English
| MEDLINE | ID: mdl-34341985
5.
Presentation and outcome with second-line treatment in AL amyloidosis previously sensitive to nontransplant therapies.
Blood
; 131(5): 525-532, 2018 02 01.
Article
in English
| MEDLINE | ID: mdl-29101236
6.
Growth differentiation factor-15 is a new biomarker for survival and renal outcomes in light chain amyloidosis.
Blood
; 131(14): 1568-1575, 2018 04 05.
Article
in English
| MEDLINE | ID: mdl-29386197
7.
High rate of profound clonal and renal responses with daratumumab treatment in heavily pre-treated patients with light chain (AL) amyloidosis and high bone marrow plasma cell infiltrate.
Am J Hematol
; 95(8): 900-905, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32282971
8.
Localized immunoglobulin light chain amyloidosis: Novel insights including prognostic factors for local progression.
Am J Hematol
; 95(10): 1158-1169, 2020 Oct.
Article
in English
| MEDLINE | ID: mdl-32602121
9.
Development and Validation of Staging Systems for AA Amyloidosis.
J Am Soc Nephrol
; 35(6): 782-794, 2024 Jun 01.
Article
in English
| MEDLINE | ID: mdl-38512269
10.
Patients with light-chain amyloidosis and low free light-chain burden have distinct clinical features and outcome.
Blood
; 130(5): 625-631, 2017 08 03.
Article
in English
| MEDLINE | ID: mdl-28546143
11.
A phase 2 trial of pomalidomide and dexamethasone rescue treatment in patients with AL amyloidosis.
Blood
; 129(15): 2120-2123, 2017 04 13.
Article
in English
| MEDLINE | ID: mdl-28130212
12.
A European collaborative study of cyclophosphamide, bortezomib, and dexamethasone in upfront treatment of systemic AL amyloidosis.
Blood
; 126(5): 612-5, 2015 Jul 30.
Article
in English
| MEDLINE | ID: mdl-25987656
13.
Nonlymphoplasmacytic lymphomas associated with light-chain amyloidosis.
Blood
; 135(4): 293-296, 2020 01 23.
Article
in English
| MEDLINE | ID: mdl-31714952
14.
Single-molecule real-time sequencing of the M protein: Toward personalized medicine in monoclonal gammopathies.
Am J Hematol
; 97(11): E389-E392, 2022 11.
Article
in English
| MEDLINE | ID: mdl-35997169
15.
Circulating free light chain measurement in the diagnosis, prognostic assessment and evaluation of response of AL amyloidosis: comparison of Freelite and N latex FLC assays.
Clin Chem Lab Med
; 55(11): 1734-1743, 2017 Oct 26.
Article
in English
| MEDLINE | ID: mdl-28343171
16.
Simple, reliable detection of amyloid in fat aspirates using the fluorescent dye FSB: prospective study in 206 patients.
Blood
; 134(3): 320-323, 2019 07 18.
Article
in English
| MEDLINE | ID: mdl-31171502
17.
Daratumumab, lenalidomide, and dexamethasone in systemic light-chain amyloidosis: High efficacy, relevant toxicity and main adverse effect of gain 1q21.
Am J Hematol
; 96(7): E253-E257, 2021 07 01.
Article
in English
| MEDLINE | ID: mdl-33844864
18.
A patient with AL amyloidosis with negative free light chain results.
Clin Chem Lab Med
; 54(6): 1035-7, 2016 Jun 01.
Article
in English
| MEDLINE | ID: mdl-26677890
19.
The impact of renal function on the clinical performance of FLC measurement in AL amyloidosis.
Clin Chem Lab Med
; 54(6): 939-45, 2016 Jun 01.
Article
in English
| MEDLINE | ID: mdl-26943606
20.
Treatment of AL amyloidosis with bendamustine: a study of 122 patients.
Blood
; 132(18): 1988-1991, 2018 11 01.
Article
in English
| MEDLINE | ID: mdl-30108065